241 related articles for article (PubMed ID: 15851482)
1. Mirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts.
Mercer SE; Ewton DZ; Deng X; Lim S; Mazur TR; Friedman E
J Biol Chem; 2005 Jul; 280(27):25788-801. PubMed ID: 15851482
[TBL] [Abstract][Full Text] [Related]
2. The cyclin-dependent kinase inhibitor p27Kip1 is stabilized in G(0) by Mirk/dyrk1B kinase.
Deng X; Mercer SE; Shah S; Ewton DZ; Friedman E
J Biol Chem; 2004 May; 279(21):22498-504. PubMed ID: 15010468
[TBL] [Abstract][Full Text] [Related]
3. Mirk/dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation.
Deng X; Ewton DZ; Mercer SE; Friedman E
J Biol Chem; 2005 Feb; 280(6):4894-905. PubMed ID: 15546868
[TBL] [Abstract][Full Text] [Related]
4. Rapid turnover of cell-cycle regulators found in Mirk/dyrk1B transfectants.
Ewton DZ; Lee K; Deng X; Lim S; Friedman E
Int J Cancer; 2003 Jan; 103(1):21-8. PubMed ID: 12455049
[TBL] [Abstract][Full Text] [Related]
5. Mirk/dyrk1B is a Rho-induced kinase active in skeletal muscle differentiation.
Deng X; Ewton DZ; Pawlikowski B; Maimone M; Friedman E
J Biol Chem; 2003 Oct; 278(42):41347-54. PubMed ID: 12902328
[TBL] [Abstract][Full Text] [Related]
6. Mirk/dyrk1B kinase destabilizes cyclin D1 by phosphorylation at threonine 288.
Zou Y; Ewton DZ; Deng X; Mercer SE; Friedman E
J Biol Chem; 2004 Jun; 279(26):27790-8. PubMed ID: 15075324
[TBL] [Abstract][Full Text] [Related]
7. Mirk/Dyrk1b mediates cell survival in rhabdomyosarcomas.
Mercer SE; Ewton DZ; Shah S; Naqvi A; Friedman E
Cancer Res; 2006 May; 66(10):5143-50. PubMed ID: 16707437
[TBL] [Abstract][Full Text] [Related]
8. Mirk/Dyrk1B: a multifunctional dual-specificity kinase involved in growth arrest, differentiation, and cell survival.
Mercer SE; Friedman E
Cell Biochem Biophys; 2006; 45(3):303-15. PubMed ID: 16845176
[TBL] [Abstract][Full Text] [Related]
9. The transcriptional activator Mirk/Dyrk1B is sequestered by p38alpha/beta MAP kinase.
Lim S; Zou Y; Friedman E
J Biol Chem; 2002 Dec; 277(51):49438-45. PubMed ID: 12384504
[TBL] [Abstract][Full Text] [Related]
10. Mirk regulates the exit of colon cancer cells from quiescence.
Jin K; Ewton DZ; Park S; Hu J; Friedman E
J Biol Chem; 2009 Aug; 284(34):22916-25. PubMed ID: 19542220
[TBL] [Abstract][Full Text] [Related]
11. The survival kinase Mirk/dyrk1B is activated through Rac1-MKK3 signaling.
Jin K; Lim S; Mercer SE; Friedman E
J Biol Chem; 2005 Dec; 280(51):42097-105. PubMed ID: 16257974
[TBL] [Abstract][Full Text] [Related]
12. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
[TBL] [Abstract][Full Text] [Related]
13. Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells.
Gao J; Zheng Z; Rawal B; Schell MJ; Bepler G; Haura EB
Cancer Biol Ther; 2009 Sep; 8(17):1671-9. PubMed ID: 19633423
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin.
Joulia D; Bernardi H; Garandel V; Rabenoelina F; Vernus B; Cabello G
Exp Cell Res; 2003 Jun; 286(2):263-75. PubMed ID: 12749855
[TBL] [Abstract][Full Text] [Related]
15. Mirk/Dyrk1B in cancer.
Friedman E
J Cell Biochem; 2007 Oct; 102(2):274-9. PubMed ID: 17583556
[TBL] [Abstract][Full Text] [Related]
16. The mitogen-activated protein kinase cascade promotes myoblast cell survival by stabilizing the cyclin-dependent kinase inhibitor, p21WAF1 protein.
Ostrovsky O; Bengal E
J Biol Chem; 2003 Jun; 278(23):21221-31. PubMed ID: 12637563
[TBL] [Abstract][Full Text] [Related]
17. Regulation of C2C12 myogenic terminal differentiation by MKK3/p38alpha pathway.
Cabane C; Englaro W; Yeow K; Ragno M; Dérijard B
Am J Physiol Cell Physiol; 2003 Mar; 284(3):C658-66. PubMed ID: 12444016
[TBL] [Abstract][Full Text] [Related]
18. The normal function of the cancer kinase Mirk/dyrk1B is to reduce reactive oxygen species.
Deng X; Mercer SE; Sun CY; Friedman E
Genes Cancer; 2014 Apr; 5(1-2):22-30. PubMed ID: 24955215
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.
Ewton DZ; Hu J; Vilenchik M; Deng X; Luk KC; Polonskaia A; Hoffman AF; Zipf K; Boylan JF; Friedman EA
Mol Cancer Ther; 2011 Nov; 10(11):2104-14. PubMed ID: 21878655
[TBL] [Abstract][Full Text] [Related]
20. Nuclear exclusion of forkhead box O and Elk1 and activation of nuclear factor-kappaB are required for C2C12-RasV12C40 myoblast differentiation.
De Alvaro C; Nieto-Vazquez I; Rojas JM; Lorenzo M
Endocrinology; 2008 Feb; 149(2):793-801. PubMed ID: 17962350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
